Flynn

34 Posts

Jeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials

The Pearl Index reported for the newly FDA-approved norelgestromin and ethinyl estradiol transdermal system (Gwyn Lo; Viatris) reflects a shift in how contraceptive efficacy is measured in modern US trials rather than a signal clinicians should find concerning, according to Jeffrey Jensen, MD, MPH, Professor, Obstetrics & Gynecology, Oregon Health & Science University. The discussion continues Jensen's reaction to the FDA approval of the once-weekly patch.1
Read More

Reproductive technologies and the federal constitutional vacuum

We are on the cusp of some revolutionary new reproductive technologies. Yet the Supreme Court has been silent on how to think about what the Constitution might have to say about the last wave of technologies dating back to the early 1980s. Questions about the propriety of destroying embryos, whether women can lawfully agree to sell their reproductive labor as surrogates, gene editing, radically new forms of family formation, as well as questions of dignity, access, and equality, cut to the quick of what kind of country we are. To the extent we view the Constitution as the ultimate repository of those values,…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.